These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18400717)

  • 21. Regulation of dectin-1-mediated dendritic cell activation by peroxisome proliferator-activated receptor-gamma ligand troglitazone.
    Kock G; Bringmann A; Held SA; Daecke S; Heine A; Brossart P
    Blood; 2011 Mar; 117(13):3569-74. PubMed ID: 21296999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-independent signaling pathways.
    Cho DH; Choi YJ; Jo SA; Jo I
    J Biol Chem; 2004 Jan; 279(4):2499-506. PubMed ID: 14593122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Celecoxib, a COX-2 inhibitor, synergistically potentiates the anti-inflammatory activity of docosahexaenoic acid in macrophage cell line.
    Kondreddy VK; Kamatham AN
    Immunopharmacol Immunotoxicol; 2016; 38(2):153-61. PubMed ID: 26954392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Troglitazone and 9cis,11trans,13trans-conjugated linolenic acid: comparison of their antiproliferative and apoptosis-inducing effects on different colon cancer cell lines.
    Yasui Y; Hosokawa M; Kohno H; Tanaka T; Miyashita K
    Chemotherapy; 2006; 52(5):220-5. PubMed ID: 16899971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Troglitazone regulates peroxisome proliferator-activated receptors and inducible nitric oxide synthase in murine ovarian macrophages.
    Minge CE; Ryan NK; Van Der Hoek KH; Robker RL; Norman RJ
    Biol Reprod; 2006 Jan; 74(1):153-60. PubMed ID: 16192401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism.
    Zhou B; Buckley ST; Patel V; Liu Y; Luo J; Krishnaveni MS; Ivan M; DeMaio L; Kim KJ; Ehrhardt C; Crandall ED; Borok Z
    PLoS One; 2012; 7(6):e38827. PubMed ID: 22745681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docosahexaenoic acid attenuates LPS-stimulated inflammatory response by regulating the PPARγ/NF-κB pathways in primary bovine mammary epithelial cells.
    He X; Liu W; Shi M; Yang Z; Zhang X; Gong P
    Res Vet Sci; 2017 Jun; 112():7-12. PubMed ID: 28095338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP.
    Wang LH; Yang XY; Zhang X; Farrar WL
    Blood; 2007 Dec; 110(13):4373-84. PubMed ID: 17785586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli.
    Guyton K; Zingarelli B; Ashton S; Teti G; Tempel G; Reilly C; Gilkeson G; Halushka P; Cook J
    Shock; 2003 Jul; 20(1):56-62. PubMed ID: 12813370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Cell Membrane Theory of Senescence" and the Role of Bioactive Lipids in Aging, and Aging Associated Diseases and Their Therapeutic Implications.
    Das UN
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33567774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells.
    Akasaki Y; Liu G; Matundan HH; Ng H; Yuan X; Zeng Z; Black KL; Yu JS
    J Biol Chem; 2006 Mar; 281(10):6165-74. PubMed ID: 16319070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways.
    Appel S; Mirakaj V; Bringmann A; Weck MM; Grünebach F; Brossart P
    Blood; 2005 Dec; 106(12):3888-94. PubMed ID: 16105976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway.
    Kim EK; Kwon KB; Koo BS; Han MJ; Song MY; Song EK; Han MK; Park JW; Ryu DG; Park BH
    Int J Biochem Cell Biol; 2007; 39(6):1260-75. PubMed ID: 17521952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
    Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
    Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional changes in rheumatoid fibroblast-like synovial cells through activation of peroxisome proliferator-activated receptor gamma-mediated signalling pathway.
    Yamasaki S; Nakashima T; Kawakami A; Miyashita T; Ida H; Migita K; Nakata K; Eguchi K
    Clin Exp Immunol; 2002 Aug; 129(2):379-84. PubMed ID: 12165097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of PPARγ agonist on SGLT2 and glucagon expressions in alpha cells under hyperglycemia.
    Kim M; Lee EJ; Shin HM; Jung HS; Kim TK; Kim TN; Kwon MJ; Lee SH; Rhee BD; Park JH
    J Endocrinol Invest; 2017 Oct; 40(10):1069-1076. PubMed ID: 28391584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists.
    Nie M; Corbett L; Knox AJ; Pang L
    J Biol Chem; 2005 Jan; 280(4):2550-61. PubMed ID: 15531761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone.
    Ban JO; Kwak DH; Oh JH; Park EJ; Cho MC; Song HS; Song MJ; Han SB; Moon DC; Kang KW; Hong JT
    Chem Biol Interact; 2010 Oct; 188(1):75-85. PubMed ID: 20540935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Troglitazone reverses the inhibition of nitric oxide production by high glucose in cultured bovine retinal pericytes.
    Kim J; Oh YS; Shinn SH
    Exp Eye Res; 2005 Jul; 81(1):65-70. PubMed ID: 15978256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.